FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3128586721> ?p ?o ?g. }

• W3128586721 endingPage "243" @default.
• W3128586721 startingPage "233" @default.
• W3128586721 abstract "Abstract Higher grade meningiomas tend to recur. We aimed to evaluate protein levels of vascular endothelial growth factor (VEGF)-A with the VEGF-receptors 1-3 and the co-receptors Neuropilin (NRP)-1 and -2 in WHO grade II and III meningiomas to elucidate the rationale for targeted treatments. We investigated 232 specimens of 147 patients suffering from cranial meningioma, including recurrent tumors. Immunohistochemistry for VEGF-A, VEGFR-1-3, and NRP-1/-2 was performed on tissue micro arrays. We applied a semiquantitative score (staining intensity x frequency). VEGF-A, VEGFR-1-3, and NRP-1 were heterogeneously expressed. NRP-2 was mainly absent. We demonstrated a significant increase of VEGF-A levels on tumor cells in WHO grade III meningiomas (p = 0.0098). We found a positive correlation between expression levels of VEGF-A and VEGFR-1 on tumor cells and vessels (p < 0.0001). In addition, there was a positive correlation of VEGF-A and VEGFR-3 expression on tumor vessels (p = 0.0034). VEGFR-2 expression was positively associated with progression-free survival (p = 0.0340). VEGF-A on tumor cells was negatively correlated with overall survival (p = 0.0084). The VEGF-A-driven system of tumor angiogenesis might still present a suitable target for adjuvant therapy in malignant meningioma disease. However, its role in malignant tumor progression may not be as crucial as expected. The value of comprehensive testing of the ligand and all receptors prior to administration of anti-angiogenic therapy needs to be evaluated in clinical trials." @default.
• W3128586721 created "2021-02-15" @default.
• W3128586721 creator A5007649453 @default.
• W3128586721 creator A5014445320 @default.
• W3128586721 creator A5014850279 @default.
• W3128586721 creator A5033111523 @default.
• W3128586721 creator A5043616847 @default.
• W3128586721 creator A5058159721 @default.
• W3128586721 creator A5065083196 @default.
• W3128586721 creator A5072405069 @default.
• W3128586721 creator A5074321110 @default.
• W3128586721 creator A5075817512 @default.
• W3128586721 creator A5077149094 @default.
• W3128586721 date "2021-02-02" @default.
• W3128586721 modified "2023-10-17" @default.
• W3128586721 title "Influence of VEGF-A, VEGFR-1-3, and neuropilin 1-2 on progression-free: and overall survival in WHO grade II and III meningioma patients" @default.
• W3128586721 cites W1527599773 @default.
• W3128586721 cites W1964949700 @default.
• W3128586721 cites W1990014340 @default.
• W3128586721 cites W1994995620 @default.
• W3128586721 cites W1995312162 @default.
• W3128586721 cites W1995840246 @default.
• W3128586721 cites W2014232946 @default.
• W3128586721 cites W2020968632 @default.
• W3128586721 cites W2041109038 @default.
• W3128586721 cites W2053221827 @default.
• W3128586721 cites W2067817921 @default.
• W3128586721 cites W2077173562 @default.
• W3128586721 cites W2090169598 @default.
• W3128586721 cites W2096549757 @default.
• W3128586721 cites W2098732827 @default.
• W3128586721 cites W2109492293 @default.
• W3128586721 cites W2133282979 @default.
• W3128586721 cites W2138602205 @default.
• W3128586721 cites W2152900094 @default.
• W3128586721 cites W2182375089 @default.
• W3128586721 cites W2261205543 @default.
• W3128586721 cites W2366536035 @default.
• W3128586721 cites W2426305918 @default.
• W3128586721 cites W2492511171 @default.
• W3128586721 cites W2598133926 @default.
• W3128586721 cites W2902272281 @default.
• W3128586721 cites W2948500453 @default.
• W3128586721 doi "https://doi.org/10.1007/s10735-020-09940-2" @default.
• W3128586721 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8012320" @default.
• W3128586721 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33528717" @default.
• W3128586721 hasPublicationYear "2021" @default.
• W3128586721 type Work @default.
• W3128586721 sameAs 3128586721 @default.
• W3128586721 citedByCount "7" @default.
• W3128586721 countsByYear W31285867212021 @default.
• W3128586721 countsByYear W31285867212022 @default.
• W3128586721 countsByYear W31285867212023 @default.
• W3128586721 crossrefType "journal-article" @default.
• W3128586721 hasAuthorship W3128586721A5007649453 @default.
• W3128586721 hasAuthorship W3128586721A5014445320 @default.
• W3128586721 hasAuthorship W3128586721A5014850279 @default.
• W3128586721 hasAuthorship W3128586721A5033111523 @default.
• W3128586721 hasAuthorship W3128586721A5043616847 @default.
• W3128586721 hasAuthorship W3128586721A5058159721 @default.
• W3128586721 hasAuthorship W3128586721A5065083196 @default.
• W3128586721 hasAuthorship W3128586721A5072405069 @default.
• W3128586721 hasAuthorship W3128586721A5074321110 @default.
• W3128586721 hasAuthorship W3128586721A5075817512 @default.
• W3128586721 hasAuthorship W3128586721A5077149094 @default.
• W3128586721 hasBestOaLocation W31285867211 @default.
• W3128586721 hasConcept C106420622 @default.
• W3128586721 hasConcept C121608353 @default.
• W3128586721 hasConcept C126322002 @default.
• W3128586721 hasConcept C142724271 @default.
• W3128586721 hasConcept C143998085 @default.
• W3128586721 hasConcept C167734588 @default.
• W3128586721 hasConcept C170493617 @default.
• W3128586721 hasConcept C204232928 @default.
• W3128586721 hasConcept C2777025900 @default.
• W3128586721 hasConcept C2777982462 @default.
• W3128586721 hasConcept C2779160599 @default.
• W3128586721 hasConcept C2779256057 @default.
• W3128586721 hasConcept C2780394083 @default.
• W3128586721 hasConcept C34425596 @default.
• W3128586721 hasConcept C502942594 @default.
• W3128586721 hasConcept C71924100 @default.
• W3128586721 hasConceptScore W3128586721C106420622 @default.
• W3128586721 hasConceptScore W3128586721C121608353 @default.
• W3128586721 hasConceptScore W3128586721C126322002 @default.
• W3128586721 hasConceptScore W3128586721C142724271 @default.
• W3128586721 hasConceptScore W3128586721C143998085 @default.
• W3128586721 hasConceptScore W3128586721C167734588 @default.
• W3128586721 hasConceptScore W3128586721C170493617 @default.
• W3128586721 hasConceptScore W3128586721C204232928 @default.
• W3128586721 hasConceptScore W3128586721C2777025900 @default.
• W3128586721 hasConceptScore W3128586721C2777982462 @default.
• W3128586721 hasConceptScore W3128586721C2779160599 @default.
• W3128586721 hasConceptScore W3128586721C2779256057 @default.
• W3128586721 hasConceptScore W3128586721C2780394083 @default.
• W3128586721 hasConceptScore W3128586721C34425596 @default.
• W3128586721 hasConceptScore W3128586721C502942594 @default.
• W3128586721 hasConceptScore W3128586721C71924100 @default.

• next